Trial Profile
A phase II study of Abicipar Pegol in patients with Diabetic Macular Edema
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 11 Aug 2015
Price :
$35
*
At a glance
- Drugs Abicipar pegol (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 11 Aug 2015 New trial record